DCGI asks TB vaccine candidates to submit more safety data after reviewing phase-3 trial results
New Delhi: The expert panel of the Drugs Controller General of India…
‘It could be E4 instead of BioE3 to boost sustainability by energy transition’
New Delhi: It could be E4 instead of BioE3 (biotechnology for economy,…